Potential antidiabetics. V. 3,5-dimethyl-4-arylazo-N-1-carbamoyl-, 3-methyl-4-arylazo-5-phenyl-N-1-carbamoyl-, and 3,5-dimethyl-4-arylazo-N-1-hippurylpyrazoles. - Suppr | 超能文献

Potential antidiabetics. V. 3,5-dimethyl-4-arylazo-N-1-carbamoyl-, 3-methyl-4-arylazo-5-phenyl-N-1-carbamoyl-, and 3,5-dimethyl-4-arylazo-N-1-hippurylpyrazoles.

作者信息

Malik W U, Garg H G, Singh P P, Arora V

出版信息

J Med Chem. 1970 Jul;13(4):780-2. doi: 10.1021/jm00298a061.

DOI:10.1021/jm00298a061

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Potential antidiabetics. V. 3,5-dimethyl-4-arylazo-N-1-carbamoyl-, 3-methyl-4-arylazo-5-phenyl-N-1-carbamoyl-, and 3,5-dimethyl-4-arylazo-N-1-hippurylpyrazoles.

J Med Chem. 1970 Jul;13(4):780-2. doi: 10.1021/jm00298a061.

2

Potential antidiabetics. XII. N- 1 -phenylcarbamoyl-4-arylazo(3- and-or 5-substituted) pyrazoles and their biological activities.

J Pharm Sci. 1972 Jun;61(6):957-9. doi: 10.1002/jps.2600610632.

3

Potential antidiabetics. 8. 4-Arylhydrazono-N'-guanylnitrate-3-methyl-2-pyrazolin-5-ones, 4-arylazo-N'-guanylnitrate-3,5-dimethylpyrazoles, and 4-arylazo-N'-guanylnitrate-3,5-diphenylpyrazoles.潜在的抗糖尿病药物。8. 4-芳基腙基-N'-硝酸胍基-3-甲基-2-吡唑啉-5-酮、4-芳基偶氮基-N'-硝酸胍基-3,5-二甲基吡唑和4-芳基偶氮基-N'-硝酸胍基-3,5-二苯基吡唑。

J Pharm Sci. 1971 Feb;60(2):323-5. doi: 10.1002/jps.2600600243.

4

Potential antidiabetics. II. 1-(2,4-dinitrophenyl)-3-methyl-4-arylazo-2-pyrazolin-5-ones.潜在的抗糖尿病药物。II. 1-（2,4-二硝基苯基）-3-甲基-4-芳基偶氮-2-吡唑啉-5-酮

J Med Chem. 1968 Sep;11(5):1104-5. doi: 10.1021/jm00311a058.

5

Potential antidiabetics. VI. 3-Methyl-4-arylhydrazono-2-isoxazolin-5-ones and 3-methyl-4-arylazo-5-(methyl-phenyl)isoxazoles.潜在的抗糖尿病药物。VI. 3-甲基-4-芳基腙基-2-异恶唑啉-5-酮和3-甲基-4-芳基偶氮-5-（甲基-苯基）异恶唑

J Med Chem. 1970 Nov;13(6):1250-1. doi: 10.1021/jm00300a070.

6

[Synthesis of new 1-(2,4-dinitrophenyl)-3-methyl-4-arylazo-2-pyrazolin-5-ones].[新型1-(2,4-二硝基苯基)-3-甲基-4-芳基偶氮-2-吡唑啉-5-酮的合成]

Rev Farm Bioquim Univ Sao Paulo. 1972 Jul-Dec;10(2):177-85.

7

Potential antidiabetics. 7. N1-(beta-hydroxybenzylmethyl)-3-methyl-4-arylhydrazono-2-pyrazolin-5-ones and N1-(beta-hydroxybenzylmethyl)-3-methyl-4-arylazo-5-methyl- or -phenylpyrazoles.

J Med Chem. 1971 Feb;14(2):175-6. doi: 10.1021/jm00284a028.

8

Potential antidiabetics: syntheses of some N1-substituted 3,5-dimethyl-pyrazoles, N1-substituted 3-methyl-2-pyrazolin-5-ones and related compounds.潜在的抗糖尿病药物：一些N1-取代的3,5-二甲基吡唑、N1-取代的3-甲基-2-吡唑啉-5-酮及相关化合物的合成

Chem Pharm Bull (Tokyo). 1975 Apr;23(4):751-3. doi: 10.1248/cpb.23.751.

9

Potential antidiabetics. 11. Preparation of 4-arylazo-3,5-disubstituted-(2H)-1,2,6-thiadiazine 1,1-dioxides.潜在的抗糖尿病药物。11. 4-芳基偶氮-3,5-二取代-(2H)-1,2,6-噻二嗪1,1-二氧化物的制备。

J Med Chem. 1972 Apr;15(4):435-6. doi: 10.1021/jm00274a035.

10

New compounds: potential antidiabetics. IV. 1-(2,4-Dinitrophenyl)-3,5-diphenyl-4-arylazopyrazoles and 1-carbamoyl-3,5-diphenyl-4-arylazopyrazoles.新化合物：潜在的抗糖尿病药物。IV. 1-(2,4-二硝基苯基)-3,5-二苯基-4-芳基偶氮吡唑和1-氨基甲酰基-3,5-二苯基-4-芳基偶氮吡唑。

J Pharm Sci. 1970 Jun;59(6):876-7. doi: 10.1002/jps.2600590641.